Want to buy for someone else? You can purchase a token at check out.

This course is free with a membership upgrade!

Upgrade to a Standard membership and gain access to 1,000+ CE and professional development courses.

Overview
Goals and Outcomes
Details
Accreditations
Overview
Overview
The goal of this course is to provide nurses and STs with an overview of the use of robotic-assisted methods during surgery.
Goals and Outcomes
Goals and Learning Outcomes

As robotic-assisted surgery grows more widespread, more perioperative professionals are likely to encounter patients scheduled for robotic surgery. Robotic-assisted surgery is evolving; as it becomes more commonplace, perioperative nurses and surgical technologists (STs) must be knowledgeable about the steps in the process of performing the setup of the trocars and robotic arm placement, as well as intraoperative management of the case.

This course provides an overview of the use of robotic-assisted methods during minimally invasive surgery. It reviews the eight components necessary for an endoscopic surgical procedure and the endoscopic functions of robotic-assisted technology. It also discusses how perioperative professionals can best interact with robotic-assisted technology.

The goal of this course is to provide nurses and STs with an overview of the use of robotic-assisted methods during surgery.


After taking this course, you should be able to:

  • List the eight components necessary for endoscopic surgical procedures
  • Describe the endoscopic functions of robotic-assisted technology
  • Discuss how healthcare professionals interact with robotic-assisted technology
  • List eight components necessary for endoscopic surgical procedures.
  • Describe the functions, benefits, disadvantages, and complications of robotic-assisted technology.
  • Discuss how perioperative professionals interact with robotic-assisted technology.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 10/01/22
Details
Course Details

Course Originally Released on : 10/1/2022

REL-ACU-0-URS

Course Author

Rhiannon Winsor

Ed.D., MBA, CST, CRCST

Brandy Verton

BSN, RN, CNOR

Nancymarie Phillips

PhD, RN, RNFA, CNOR(E)

Nancy Bellucci

PhD, RN, CNOR

Accreditations
Accreditations

NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Accreditations imageAccreditations image

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.